USP22
Basic information
Region (hg38): 17:20999596-21043760
Previous symbols: [ "USP3L" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- not_specified (31 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the USP22 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000015276.2. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 0 | |||||
| missense | 35 | 1 | 36 | |||
| nonsense | 1 | 1 | ||||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 1 | 1 | ||||
| Total | 0 | 0 | 37 | 1 | 0 |
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| USP22 | protein_coding | protein_coding | ENST00000261497 | 13 | 44164 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 124788 | 0 | 8 | 124796 | 0.0000321 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 3.56 | 130 | 305 | 0.426 | 0.0000180 | 3472 |
| Missense in Polyphen | 24 | 108.75 | 0.22069 | 1274 | ||
| Synonymous | 1.20 | 111 | 128 | 0.865 | 0.00000872 | 941 |
| Loss of Function | 3.91 | 6 | 28.6 | 0.210 | 0.00000154 | 323 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.0000291 | 0.0000291 |
| Ashkenazi Jewish | 0.00 | 0.00 |
| East Asian | 0.0000556 | 0.0000556 |
| Finnish | 0.00 | 0.00 |
| European (Non-Finnish) | 0.0000553 | 0.0000530 |
| Middle Eastern | 0.0000556 | 0.0000556 |
| South Asian | 0.00 | 0.00 |
| Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Histone deubiquitinating component of the transcription regulatory histone acetylation (HAT) complex SAGA. Catalyzes the deubiquitination of both histones H2A and H2B, thereby acting as a coactivator. Recruited to specific gene promoters by activators such as MYC, where it is required for transcription. Required for nuclear receptor-mediated transactivation and cell cycle progression. {ECO:0000269|PubMed:18206972, ECO:0000269|PubMed:18206973, ECO:0000269|PubMed:18469533}.;
- Pathway
- Post-translational protein modification;Metabolism of proteins;Chromatin modifying enzymes;HATs acetylate histones;Ub-specific processing proteases;Deubiquitination;Chromatin organization
(Consensus)
Recessive Scores
- pRec
- 0.104
Intolerance Scores
- loftool
- 0.153
- rvis_EVS
- -0.38
- rvis_percentile_EVS
- 27.42
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.755
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Zebrafish Information Network
- Gene name
- usp22
- Affected structure
- brain
- Phenotype tag
- abnormal
- Phenotype quality
- bulbous
Gene ontology
- Biological process
- ubiquitin-dependent protein catabolic process;cell cycle;embryo development ending in birth or egg hatching;histone ubiquitination;histone deubiquitination;protein deubiquitination;histone H4 acetylation;positive regulation of transcription, DNA-templated;positive regulation of mitotic cell cycle
- Cellular component
- SAGA complex;nucleoplasm;nuclear speck;SAGA-type complex
- Molecular function
- transcription coactivator activity;thiol-dependent ubiquitin-specific protease activity;protein binding;zinc ion binding;H4 histone acetyltransferase activity;enzyme binding;nuclear receptor transcription coactivator activity;thiol-dependent ubiquitinyl hydrolase activity